Skip to main content
. 2020 Sep 11;4:129. Originally published 2019 Sep 4. [Version 2] doi: 10.12688/wellcomeopenres.15408.2

Table 3. The estimated cost of the different regimens.

Treatment Drugs (US$) Tests
(US$)
Consultation
fees (US$)
Total treatment cost
(US$)
Total Average
per week
Genotype 2/3: 24-week treatment regimen
IFN α-2a + ribavirin 619.17 – 655.17 25.79 - 27.30 498.18 13.95 1,155.29 – 1,167.31
IFN α-2b + ribavirin 607.75 – 619.77 25.32 - 25.82 498.18 13.95 1,119.88 – 1,131.90
Peg-IFN α-2a +
ribavirin
1,644.14 – 2,617.89 68.50 - 109.07 498.18 13.95 2,156.27 – 3,130.02
Peg-IFN α-2b +
ribavirin
1,680.07 – 1,967.78 70.00 - 81.99 498.18 13.95 2,192.20 – 2,470.91
Genotype 1/4/6: 48-week treatment regimen
IFN α-2a + ribavirin 1,325.52 – 1,333.78 27.61 - 27.79 613.24 24.41 1,953.84 – 1,961.90
IFN α-2b + ribavirin 1,254.71 – 1,262.97 26.14 - 26.31 613.24 24.41 1,882.83 – 1,892.09
Peg-IFN α-2a +
ribavirin
3,327.48 – 5,259.20 69.32 - 109.57 613.24 24.41 3,955.60 – 5,887.32
Peg-IFN α-2b +
ribavirin
3,375.89 – 3,950.73 70.33 - 82.30 613.24 24.41 4,003.43 – 4,578.85

The range in the costs for a given regimen is due to the variation in the costs of the different brands of the drugs and the different dosages (minimum and maximum values are shown in Table 4). Costs are in 2017 prices.